SEQENS Is Unveiling Its Main Innovation and Development Centre
June 18, 2019PORCHEVILLE, France–(BUSINESS WIRE)–A 34,000-square-metre science platform, SEQENS’Lab offers a unique
ecosystem, dedicated to our customers to accelerate their projects from
the early research and development stages to commercial scale
production. Close to Paris, SEQENS’Lab is the centre of excellence for
developing a totally unique package of R&D services.
SEQENS’Lab is a development accelerator, dedicated to our customers
As an R&D centre that meets the highest standards, SEQENS’Lab has
assembled the group’s key skills and expertise in recognised areas of
excellence such as: organic chemistry development at the forefront of
the latest innovations, two referring laboratories in Physics &
Solid-State Chemistry as well as in Process Safety, kinetic and
thermodynamic simulation tools, large batch manufacturing capabilities
for preclinical and clinical studies, all in an environment that adheres
to cGMP.
Furthermore, it has innovative means for developing future processes,
particularly in flow chemistry, that are more productive and
energy-efficient and have minimal environmental impact.
Innovative SMEs and start-ups that are specialised in analytical
services and CROs will be hosted at SEQENS’Lab, giving our customers
access to complementary skills in one place. The example of GenEvolution
demonstrates this: partner from the very beginning, it brings key skills
to SEQENS’Lab in toxicology for medicine, chemical ingredients, plant
extracts and cosmetic ingredient evaluation thanks to the
miniaturization of its in-vitro tests.
SEQENS’Lab is an appealing and modern place, it reflects the group’s
development dynamic
“The SEQENS’ Lab will also welcome external resources, innovative
start-ups and our historic partners, forming a dynamic and cohesive
ecosystem in service of innovation. We also want to facilitate
interactions with our academic partners and create a LabCom with CNRS
(French National Centre for Scientific Research) to design and develop
highly innovative solutions,” added Christophe Eychenne-Baron, R&D
director.
About SEQENS
SEQENS is an integrated global leader in pharmaceutical synthesis and
specialty ingredients.
With 24 manufacturing sites and 3 R&D centers in Europe, North America
and Asia, SEQENS develops custom solutions and ingredients for the most
demanding industries such as healthcare, electronics, cosmetics, food
and homecare.
Contacts
Aline Rancony
[email protected]
(+33)
6 79 18 53 92
